St. Louis, MO (PRWEB) September 23, 2013

Appistry, Inc., a leading provider of high-performance computing and analytics solutions for next-generation medicine and the authorized distributor of select genetic analysis tools from the Broad Institute, today announced its chief scientific officer, Dr. Richard Mazzarella, will deliver a presentation titled Clinical Best Practices for Cancer Genetic Analysis Pipelines, at Cambridge HealthTech Institutes inaugural Clinical Genomics for Cancer Diagnostics Conference in Boston Sept. 23-24 at the Seaport Hotel. In his presentation, which will kick off the Data Interpretation conference track on Sept. 24, Mazzarella will illustrate how the use of de facto standard genetic analysis tools enables labs to commit more bioinformatics resources to more challenging and less well-understood pipeline development tasks.

Genetic analysis is a rapidly changing field, but certain tools are emerging as best practices because they have been used in a wide range of studies and in large-scale efforts such as The Cancer Genome Atlas and the International Cancer Genome Consortium, Mazzarella said. Running pipelines based on these validated tools conserves development effort for those analysis tasks that require truly innovative approaches and more extensive evaluation.

Appistry, a sponsor of the conference, will also exhibit its software solutions geared toward helping clinical labs take their next-generation sequencing (NGS) pipelines into production. As an exhibitor at booth number 7, Appistry will share with conference attendees the challenges of implementing NGS sequencing in clinical labs in the context of its computing environment, Ayrris. The technology applies computing capabilities developed for the analysis of big data in sectors such as finance and defense to the analysis of genetic data and the development of next-generation medicine.

The Clinical Genomics for Cancer Diagnostics Conference will examine novel diagnostic tools and techniques, evaluate their benefit to patient outcome, and focus on steps to implementation. The two-day event will gather leaders in cancer genomics, bioinformatics, clinical genomics, pharmacogenomics, diagnostics, internal medicine, molecular biology, and translational research.

Following the conference, Appistry will also host a webinar featuring the latest pipeline and tools for cancer genetic analysis from the Broad Institute. The one-hour webinar titled Which Mutations Matter: Analyzing and Annotating Cancer Genomes, will take place on Oct. 3, 2013 at 12 p.m. EDT. For more information and to register for the free event, please visit appistry.com/webinar.

About Appistry Appistry (http://www.appistry.com) orchestrates solutions to big data problems and since 2001, Appistrys fabric technology has empowered organizations and researchers to transform vast data into actionable intelligence. Appistry leverages its fabric computing technology to power Ayrris, a big-data environment that weaves together high performance computing and analytics to provide the throughput and scale required for diverse applicationsfrom discovering new medical therapies to delivering overnight packages, gaining clarity from financial transactions, or deciphering military satellite images. Appistry is the authorized distributor of the GATK and select genetic analysis tools from the Broad Institute for use in for-profit settings. For the latest Appistry news, visits us on Facebook, Twitter and LinkedIn.

More:
Appistry Chief Scientific Officer to Speak at Inaugural Conference on Delivering Genome-Enabled Diagnostics in the ...

Comments are closed.